MII IG PRO
2026.2.0 - ci-build
Unknown region code '276'
MII IG PRO, published by Medizininformatik-Initiative. This guide is not an authorized publication; it is the continuous build for version 2026.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/medizininformatik-initiative/kerndatensatzmodul-proms/ and changes regularly. See the Directory of published versions
This page includes translations from the original source language in which the guide was authored. Information on these translations and instructions on how to provide feedback on the translations can be found here.
Domain-based scoring enables comparability across different PRO instruments by mapping them onto shared health domains. Rather than treating questionnaire scores in isolation, measurements are transformed into standardized domain metrics – primarily PROMIS T-Scores (Mean=50, SD=10).
This approach addresses a central challenge in modern health services research: the harmonization of patient-reported outcomes collected with heterogeneous instruments across clinical sites, studies, and care settings.
Two recent 2025 publications provide empirical evidence for the methodological validity of the domain-based harmonization approach:
Intra-Domain Harmonization (Riazy et al., 2025)
Riazy et al. present population-based reference data for six established depression instruments (PHQ-9, PHQ-8, CES-D 8, PROMIS Depression SF 4a/8a, WHO-5) from 29 European countries (n=287,530) based on the EHIS Wave 3 survey. The study demonstrates the feasibility of harmonizing different instruments within a single health domain and supports the domain-specific score transformation approach pursued in the MII PRO Module.
Reference: Riazy L, Grote M, Liegl G, Rose M, Fischer F. Cross-Sectional Reference Data From 29 European Countries for 6 Frequently Used Depression Measures. JAMA Netw Open. 2025;8(6):e2517394.
Cross-Domain Harmonization (Oerlemans et al., 2025)
Oerlemans et al. developed and validated crosswalks between the multidimensional EORTC QLQ-C30 and domain-specific PROMIS instruments. The achieved correlations (r = 0.65-0.85) across seven health domains demonstrate the practicability of transforming multi-domain assessments into domain-specific metrics. This methodology enables the integration of established comprehensive instruments into a domain-based architecture.
Reference: Oerlemans S, et al. Crosswalks between EORTC QLQ-C30 and PROMIS measures: Harmonizing patient-reported outcomes across cancer trials. J Clin Epidemiol. 2025. DOI: 10.1016/j.jclinepi.2025.111705.
Implications for the MII PRO Implementation
These publications provide important empirical foundations for the conceptual direction of the MII PRO Module:
The temporal proximity of these publications to the balloting process prevented their full integration into the current version; however, they confirm the chosen architecture and inform future developments.
Related pages:
Different questionnaires often measure the same construct:
Domain-based scoring enables comparability through transformation onto a common metric (T-Scores with Mean=50, SD=10).
The depression domain serves as the first fully implemented domain, demonstrating the approach:
ObservationDefinition: mii-obsdef-pro-depression-t-score
+-- Code: LOINC#77861-3 "PROMIS Depression T-score"
+-- Reference Ranges: EHIS Wave 3 (n=287,530)
+-- Population Norms: DE, EU, age-stratified
Observation: Depression T-Score Instance
+-- instantiates: ObservationDefinition
+-- derivedFrom: QuestionnaireResponse or Raw Score
+-- method: IRT calculation or Cross-Walking
Riazy et al. (2025) provide comprehensive reference data from 29 European countries for 6 frequently used depression instruments (JAMA Netw Open 2025):
Instruments with normative data:
Sample:
Application for MII PRO:
1. Item Response Theory (IRT)
Figure 1: Item Response Theory – Response probabilities as a function of trait level
The figure shows the characteristic curves of Item Response Theory:
IRT advantages:
2. Cross-Walking Tables
Newly validated crosswalks (2025): Oerlemans et al. developed comprehensive crosswalks between EORTC QLQ-C30 and PROMIS (J Clin Epidemiol 2025):
The following limitations should be considered when applying cross-walking:
Recommendation: For clinical decisions, mapping confidence intervals should be considered. For research purposes, use with transparent documentation of mapping error is acceptable.
Figure 2: The trade-off between number of items, measurement range, and precision
This figure illustrates a fundamental dilemma in PRO instrument selection:
Domain-based scoring resolves this dilemma through:
Figure 3: Item banking for the Physical Function domain
The item banking concept enables:
This adaptive strategy enables precise measurement across the full ability spectrum with minimal patient burden.
A patient starts with PHQ-9 in a primary care practice, then switches to PROMIS Depression in a hospital setting:
Different centers use different instruments:
All data become comparable through domain T-Scores.
Benchmarking across institutions:
// FSH
Instance: PHQ9-to-PROMIS-Depression
InstanceOf: ConceptMap
* sourceCanonical = "Questionnaire/phq-9"
* targetCanonical = "ObservationDefinition/depression-t-score"
* group.element[+]
* code = #score-range-0-4
* target.code = #t-score-40-45
* target.equivalence = #equivalent
// CQL
define "Depression T-Score from PHQ-9":
case
when PHQ9Score between 0 and 4 then 42.5
when PHQ9Score between 5 and 9 then 50.0
when PHQ9Score between 10 and 14 then 60.0
when PHQ9Score between 15 and 19 then 70.0
when PHQ9Score >= 20 then 77.5
else null
end
Fully implemented:
In development:
Planned (2026+):
Domain scores are represented as FHIR Observations with specific ObservationDefinitions:
// Structure
ObservationDefinition
+-- code: LOINC code for domain score (e.g., 77861-3 for PROMIS Depression)
+-- method: Calculation method (IRT, cross-walking, equipercentile)
+-- qualifiedInterval: Population-specific reference ranges
+-- preferredReportName: Standardized designation
Observation
+-- code: Reference to ObservationDefinition
+-- valueQuantity: T-Score (Mean=50, SD=10)
+-- derivedFrom: Source QuestionnaireResponse or Observation
+-- method: Mapping method used
Clinical Care:
Research:
Quality Assurance:
Since ObservationDefinitions in FHIR R4 do not support canonical URLs and cannot be rendered directly in the IG, the following overview provides structured access to all defined score definitions:
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | PHQ-9 | Total Score | 44261-6 | 0-27 | mii-obsdef-pro-phq-9-total-score | MII_PR_PRO_PHQ9_Score | | BDI-II | Total Score | 89209-1 | 0-63 | mii-obsdef-pro-score-bdi-ii | MII_PR_PRO_BDI_II_Score | | PROMIS Depression | T-Score | 77861-3 | 20-80 | mii-obsdef-pro-depression-t-score | MII_PR_PRO_Depression_TScore | | PROMIS-29 Depression | T-Score | 71958-6 | 20-80 | mii-obsdef-pro-promis-29-depression-tscore | MII_PR_PRO_PROMIS_29_Depression_TScore | | PROMIS Cognitive Function SF4a | Raw Score | 81533-2 | 4-20 | mii-obsdef-pro-promis-cognitive-function-sf4a-raw-score | MII_PR_PRO_PROMIS_Cognitive_Function_SF4a_Raw_Score | | PROMIS Cognitive Function SF4a | T-Score | 81538-1 | 20-80 | mii-obsdef-pro-promis-cognitive-function-sf4a-tscore | MII_PR_PRO_PROMIS_Cognitive_Function_SF4a_TScore |
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | PROMIS-29 Anxiety | T-Score | 71953-7 | 20-80 | mii-obsdef-pro-promis-29-anxiety-tscore | MII_PR_PRO_PROMIS_29_Anxiety_TScore |
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | PROMIS-29 Physical Function | T-Score | 71962-8 | 20-80 | mii-obsdef-pro-promis-29-physical-function-tscore | MII_PR_PRO_PROMIS_29_Physical_Function_TScore |
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | EQ-5D-5L | Index Score | 91382-2 | -0.661 to 1.0 | mii-obsdef-pro-score-eq5d5l-index | MII_PR_PRO_Observation_EQ5D5L_Index | | EQ-5D-5L | VAS | 91383-0 | 0-100 | mii-obsdef-pro-score-eq5d5l-vas | MII_PR_PRO_Observation_EQ5D5L_VAS | | EQ-5D-5L | Profile | 91381-4 | 11111-55555 | mii-obsdef-pro-score-eq5d5l-profile | MII_PR_PRO_Observation_EQ5D5L_Profile |
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | PROMIS-29 Fatigue | T-Score | 71959-4 | 20-80 | mii-obsdef-pro-promis-29-fatigue-tscore | MII_PR_PRO_PROMIS_29_Fatigue_TScore | | PROMIS-29 Sleep Disturbance | T-Score | 71964-4 | 20-80 | mii-obsdef-pro-promis-29-sleep-disturbance-tscore | MII_PR_PRO_PROMIS_29_Sleep_Disturbance_TScore |
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | PROMIS-29 Pain Intensity | 0-10 Scale | 71965-1 | 0-10 | mii-obsdef-pro-promis-29-pain-intensity | MII_PR_PRO_PROMIS_29_Pain_Intensity | | PROMIS-29 Pain Interference | T-Score | 71961-0 | 20-80 | mii-obsdef-pro-promis-29-pain-interference-tscore | MII_PR_PRO_PROMIS_29_Pain_Interference_TScore |
| Instrument | Score Type | LOINC Code | Range | ObservationDefinition | Observation Profile | |————|———–|————|———|———————-|———————| | PROMIS-29 Social Function | T-Score | 71966-9 | 20-80 | mii-obsdef-pro-promis-29-social-function-tscore | MII_PR_PRO_PROMIS_29_Social_Function_TScore |
ObservationDefinition Properties:
Usage in Practice:
// FSH
Observation
+-- code: LOINC code from ObservationDefinition
+-- valueQuantity: Calculated score
+-- extension[instantiatesCanonical]: Reference to ObservationDefinition
+-- derivedFrom: QuestionnaireResponse or other Observation
Domain-based scoring is essential for the harmonization of PRO data in the German healthcare system. The depression domain demonstrates practical feasibility and provides the foundation for additional domains. Despite methodological challenges in cross-walking, the benefits for clinical care and research clearly outweigh the limitations.
Further information: